每年研究產出
每年研究產出
- 4結果
搜尋結果
-
2024
Editorial: High qHBsAg—Is it a good or bad signal? Authors' reply
Lin, H. C., Jeng, W. J. & Yang, H. I., 06 2024, 於: Alimentary Pharmacology and Therapeutics. 59, 12, p. 1618-1619 2 p.研究成果: 期刊稿件 › 社論
開啟存取 -
2023
Editorial: considerations for expanding treatment in grey zone chronic hepatitis B patients
Liu, Y. C. & Jeng, W. J., 03 2023, 於: Alimentary Pharmacology and Therapeutics. 57, 5, p. 577-578 2 p.研究成果: 期刊稿件 › 社論
開啟存取1 引文 斯高帕斯（Scopus） -
2022
Editorial: is functional cure the only holy grail for treatment discontinuation in patients with HBeAg-negative chronic hepatitis B?
Liu, Y. C. & Jeng, W. J., 08 2022, 於: Alimentary Pharmacology and Therapeutics. 56, 3, p. 544-545 2 p.研究成果: 期刊稿件 › 社論
開啟存取 -
2014
Finite entecavir therapy is a feasible alternative to indefinite therapy
Jeng, W. J., 01 11 2014, 於: Hepatology. 60, 5, p. 1796-1797 2 p.研究成果: 期刊稿件 › 社論
開啟存取